Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Anthony Palmieri, PharmD, MBA
Articles
The Impact of Abuse Deterrent Technologies on Prescription Opioid Trends
Howard Oremland, RPh, MBA;Lauren G. Gallagher, MPH;John Schlie, PharmD;Dick Creager, MD, MPA;Anthony Palmieri, PharmD, MBA;Olga S. Matlin, PhD;Steven M. Kymes, PhD
October 11th 2013The authors examined trends in the utilization of prescription opioid medication following introduction of abuse deterrent technology for Oxycontin.
Read More
The Expanding Role of New Medications in the Treatment of Type 2 Diabetes Mellitus
Kristen Harrison, MPH;Frederick Brown, PharmD;Brandeis Seymore, RPh;Anthony Palmieri, PharmD, MBA;Olga S. Matlin, PhD;Steven M. Kymes, PhD
August 21st 2013We examined the prevalence of use and cost impact of DPP-4 inhibitors and GLP-1 receptor agonists in people with diabetes.
Read More
Latest Updated Articles
Published: October 23rd 2024 | Updated: October 24th 2024
What to Know About E Coli Outbreak Linked to McDonald’s Quarter Pounders
Published: January 18th 2016 | Updated: October 18th 2024
10 Pharmacy Quotes That Will Make You Rethink the Profession
Published: September 22nd 2015 | Updated: October 14th 2024
Gabapentin Differs From Pregabalin in Several Key Ways
Published: August 30th 2024 | Updated: November 21st 2024
Congress Requests Corrections to Testimony From Three Largest Pharmacy Benefit Manager Executives Following FTC Report
Published: October 8th 2024 | Updated: November 21st 2024
What Drug Rates Are Reported in Price Transparency Data?
Published: October 7th 2024 | Updated: November 21st 2024
What Went Wrong: How Formularies, Contracts, and Rebates Created a Headwind for Biosimilars
